USA Authorized Visivra Retailer Lot VIS-26/VI-5716 One capsule a day · 30 per bottle 60-day money-back guarantee

Visivra Official Website › About

About

About Visivraes And How This Visivra Website Is Written

By the Visivra Team at Visivraes · Medical review: Dr. Steven Christiansen, MD · Revised

Visivraes is the USA Authorized Visivra Retailer, operating from New York.

It sells the product and publishes this website. It did not formulate Visivra, does not manufacture it and has no laboratory. What it can do is transcribe a label, verify a citation against its own record, date a price and publish a correction. Everything here follows from that boundary.

A retail desk with a stated method, five standing refusals and a correction route that actually changes the page.

Medical review

The physician who reviews the Visivra pages

Dr. Steven Christiansen, MD is a physician. Dr. Steven Christiansen, MD reads the Visivra pages on this website for medical accuracy: the product copy, the label transcription, the ingredient and safety sections, and the journal posts. Each page names the reviewer under its title and shows the date it was last revised.

A medical review checks that a page agrees with the label and with the sources it cites, and that its safety notes go far enough. It is not an endorsement of Visivra, and it is not advice about your own eyes. What the review covers.

Who publishes this

What Visivraes is, and what it is not

A retail desk in New York, with a clear boundary around what it can honestly claim to know.

Visivraes is the USA Authorized Visivra Retailer. It is a retail desk: it sells the product, it publishes this website, and it operates from New York. It did not formulate Visivra, does not manufacture it, and has no laboratory.

Saying so is not modesty. It sets the boundary of what this desk can honestly tell you. It can transcribe a label, read a seller's page, verify a citation, do arithmetic on a price ladder and publish a correction. It cannot assay a capsule, confirm an amount the manufacturer has not printed, or tell you what your own eyes will do.

Two addresses, kept deliberately apart. The office is at 5 Times Square, Floor 18, New York, NY 10036, USA. Returns are received at 320 Park Avenue, Floor 15, New York, NY 10022, USA, which is a different place and is not a walk-in address.

The Visivraes site mark, a blue roundel with an eye
The desk's own markThe eye roundel this website uses across its pages and its favicons. It is this desk's mark, not the manufacturer's.
The Visivra two-bottle pack, front labels showing
What the desk sellsThe entry rung of the ladder. Two bottles, sixty capsules, and the only pack whose supply and refund window end on the same day.
The method

How this desk writes a Visivra page

Read the label artwork before the copy

Every product render in the pack is opened and read. Where the artwork and the written paperwork disagree, the artwork wins, because the bottle is what arrives in the box.

Read the seller's own page, and date it

Prices, tier labels and claims are read from the seller's page and the date is printed: 19 September 2026. A price without a date is a price that will quietly become wrong.

Verify every citation against its own record

Each PubMed record on this site was found by search and read back through the summary interface in the session that wrote these pages. Authors, journal, year, volume and pages come from that record.

Capture the amount each trial used

Where a dose decides what a page may say, the abstract itself is read and the figure taken out of it. Those figures are the only milligrams on this site, and each is labelled as the trial's.

Quarantine the awkward part

The label comparison lives on one page and in one section of the home page. Repeating it in twenty places would make an ordinary product read as a scandal, which would be its own distortion.

Refusals

What this Visivra desk refuses to publish

Five things, and they are refusals rather than omissions.

  • An estimated amount for any of the six. The label prints none and a plausible-looking figure would be a fabrication with a decimal point in it.
  • A borrowed credential. The only clinician named on this site is the physician who reviews it, and no page presents that review as a recommendation of the product.
  • A claim beyond the four on the pack. The seller's page carries three more and they do not travel.
  • A PMID nobody looked up. Every citation on this site was verified against its own record before it was written down.
  • A star rating this desk generated. The aggregate belongs to the distributor and is always attributed to it.
Corrections

How to correct a Visivra page on this website

Corrections are the part of an editorial policy that is easiest to write and hardest to mean, so here is the mechanism rather than the sentiment.

Write to the website desk, whose inbox is listed in the site footer, which is staffed Mon–Fri 9:00am–5:00pm ET and handles this website: pages, typos, privacy and press. Name the page and quote the line. If you are holding a bottle whose panel differs from the transcription on the label page, say what yours says.

A correction goes onto the page itself rather than into a log nobody reads, and the review date at the foot of the page moves forward when it does. That date is the clearest signal a reader has about how fresh a page is, and on this site it currently reads September 30, 2026.

What that address cannot do is see an order. It has no access to the order system at all. Tracking, changes and refunds go to the order desk, whose telephone and email are both in the site footer, and a refund request sent to the website address costs a day in redirection.

The commercial relationship

What this desk earns when you buy Visivra

This website is a retail desk and it is paid when someone buys through it. That is the commercial relationship and it belongs on the page rather than in a footnote.

The reason to say so in the same paragraph as everything above is that a reader is entitled to weigh it. A site that scores a product 1.5 out of 5 on label disclosure, prints the amounts its ingredients were tested at beside an empty column, and lists four groups who should not buy it, is not doing the thing a pure sales page does. But it is still paid on sales, and knowing that is part of reading it properly.

The practical protection a reader has is not this desk's good intentions. It is the 60-day window, administered by the order desk, with opened bottles included. That is a mechanism rather than a promise, and it is why it is mentioned on every page.

The byline

The Visivra Team byline, and the physician behind the review

Every page here is written by the Visivra Team at Visivraes, the desk that sells the product and keeps this website. The team transcribes the label, reads the seller’s page, looks up each study and does the arithmetic on the price ladder.

Before a page goes up, Dr. Steven Christiansen, MD, a physician, reads it for medical accuracy, and the byline under each page title says so, with the revision date beside it. The reviewer is named because the review happened, not to lend the product authority: no page quotes the reviewer recommending Visivra.

The method above can still be checked by any reader: open the label artwork, read the seller’s page, look up a PubMed record, and see whether the amounts on this site are labelled as the trials’ own. The full process is on our review process page.

Sources and sign-off

Who publishes this Visivra website?

  1. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial — Age-Related Eye Disease Study 2 (AREDS2) Research Group (JAMA, 2013;309(19):2005-15). PMID 23644932: https://pubmed.ncbi.nlm.nih.gov/23644932/
  2. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration — Evans JR, Lawrenson JG (Cochrane Database Syst Rev, 2023;9(9):CD000254). PMID 37702300: https://pubmed.ncbi.nlm.nih.gov/37702300/
  3. Astaxanthin (AstaReal) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double-Blind Placebo-Controlled Trial — Hecht KA, Marwah M, Wood V, et al (Adv Ther, 2025;42(4):1811-1833). PMID 40014233: https://pubmed.ncbi.nlm.nih.gov/40014233/
  4. A 12-Week-Long Intake of Bilberry Extract (Vaccinium myrtillus L.) Improved Objective Findings of Ciliary Muscle Contraction of the Eye: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Comparison Trial — Kosehira M, Machida N, Kitaichi N (Nutrients, 2020;12(3)). PMID 32106548: https://pubmed.ncbi.nlm.nih.gov/32106548/
A single Visivra bottle, front label, 30 capsules

Order Visivra from the desk that publishes this

The same desk that scored its label disclosure 1.5 out of 5 is the one taking the order. The sixty-day window is what makes that safe to act on.

Two bottles $158 · six bottles $294 · 60-day money-back guarantee

Order Visivra On The Official Website

One capsule a day · 30 per bottle · lot VIS-26/VI-5716

60-day money-back guarantee

Two months, which is roughly the shortest honest test of an eye capsule

The trials behind these six ingredients ran for eight weeks, twelve weeks, eighty-four days and five years. None of them ran for a fortnight. The window runs 60 days from the date of purchase, opened bottles included. Call the order desk with your order ID and follow the steps on the refund policy page.

Order Visivra On The Official Website

Lot VIS-26/VI-5716 · from $49 a bottle · read the guarantee first

The Visivra six-bottle pack, front labels showing
Visivra · one capsule a day $49 a bottle on the six-pack · 60-day money-back guarantee
Add To Cart